ProShare Advisors’s MediciNova MNOV Stock Holding History

ProShare Advisors’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,461	Closed	-$40K	–	2343
2021 Q3	$40K	Buy	+10,461	New	+$39.7K	﹤0.01%	1974
2021 Q2	–	Sell	-18,203	Closed	-$92K	–	2389
2021 Q1	$92K	Buy	18,203 +1,753	+11%	+$10.2K	﹤0.01%	2174
2020 Q4	$87K	Buy	+16,450	New	+$94.3K	﹤0.01%	2004
2019 Q4	–	Sell	-16,426	Closed	-$131K	–	1796
2019 Q3	$131K	Sell	16,426 -367	-2%	-$3.27K	﹤0.01%	1512
2019 Q2	$162K	Sell	16,793 -1,867	-10%	-$19.7K	﹤0.01%	1478
2019 Q1	$155K	Buy	18,660 +264	+1%	+$2.3K	﹤0.01%	1517
2018 Q4	$150K	Buy	+18,396	New	+$184K	﹤0.01%	1426
2017 Q4	–	Sell	-22,034	Closed	-$140K	–	1803
2017 Q3	$140K	Buy	22,034 +1,413	+7%	+$7.51K	﹤0.01%	1308
2017 Q2	$108K	Sell	20,621 -1,226	-6%	-$6.87K	﹤0.01%	1397
2017 Q1	$131K	Sell	21,847 -5,708	-21%	-$34.4K	﹤0.01%	1493
2016 Q4	$166K	Buy	+27,555	New	+$194K	﹤0.01%	1633

Other funds holding MNOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ProShare Advisors's MNOV Position: Q4 2021 in Review

ProShare Advisors sold out of MediciNova (MNOV) in Q4 2021, closing a stake of 10,461 shares — an estimated $40K sold.

ProShare Advisors first reported a position in MNOV in Q4 2016 and held it in 11 quarters. The position peaked at $166K in Q4 2016. 42 funds tracked by Wall St. Rank hold MNOV as of Q4 2021.

ProShare Advisors reported no remaining MediciNova position as of Q4 2021 after selling out during the quarter.
ProShare Advisors sold 10,461 MediciNova shares in Q4 2021, an estimated $40K.
ProShare Advisors first reported a position in MediciNova in Q4 2016 and held it in 11 quarters.
ProShare Advisors's MediciNova position peaked at $166K in Q4 2016.
42 funds tracked by Wall St. Rank held MediciNova as of Q4 2021.

Based on ProShare Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.